Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment lineKenji Nakano, Shunji Takahashi, Junichi Tomomatsu et al.|Molecular and Clinical Oncology|2020Cited by 9
Retrospective Analysis of Trabectedin Therapy for Soft Tissue SarcomaKuniki Kawaguchi, Shunji Takahashi, Kenji Nakano et al.|In Vivo|2019Cited by 7
Clinical significance of relative dose intensity during pazopanib treatment to advanced/metastatic soft tissue sarcoma (STS) patients.Kenji Nakano, Shunji Takahashi, Seiichi Matsumoto et al.|Journal of Clinical Oncology|2016Cited by 0